rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-4-8
|
pubmed:abstractText |
The late Dr. Vincent McGovern (1915 to 1983) was an international authority on melanoma pathology and one of the first to suggest that assessment of tumor mitotic rate (TMR) might provide useful prognostic information. Data for a large cohort of patients, now with extended follow-up, whose tumors had been assessed by Dr. McGovern were analyzed to reassess the independent prognostic value of TMR in primary localized, cutaneous melanoma.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1068-9265
|
pubmed:author |
pubmed-author:AccorttNeil ANA,
pubmed-author:AzzolaManuela FMF,
pubmed-author:ColmanMarjorie HMH,
pubmed-author:FranckenAnne BrechtAB,
pubmed-author:McCarthyWilliam HWH,
pubmed-author:McGovernVincent JVJ,
pubmed-author:MiltonGerald WGW,
pubmed-author:ScolyerRichard ARA,
pubmed-author:ShawHelen MHM,
pubmed-author:SoongSeng-jawSJ,
pubmed-author:ThompsonJohn FJF
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
426-33
|
pubmed:dateRevised |
2007-7-18
|
pubmed:meshHeading |
pubmed-meshheading:15070604-Adolescent,
pubmed-meshheading:15070604-Adult,
pubmed-meshheading:15070604-Aged,
pubmed-meshheading:15070604-Aged, 80 and over,
pubmed-meshheading:15070604-Child,
pubmed-meshheading:15070604-Female,
pubmed-meshheading:15070604-Humans,
pubmed-meshheading:15070604-Male,
pubmed-meshheading:15070604-Melanoma,
pubmed-meshheading:15070604-Middle Aged,
pubmed-meshheading:15070604-Mitotic Index,
pubmed-meshheading:15070604-Neoplasm Staging,
pubmed-meshheading:15070604-Predictive Value of Tests,
pubmed-meshheading:15070604-Prognosis,
pubmed-meshheading:15070604-Proportional Hazards Models,
pubmed-meshheading:15070604-Skin Neoplasms,
pubmed-meshheading:15070604-Survival Analysis
|
pubmed:year |
2004
|
pubmed:articleTitle |
The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
|
pubmed:affiliation |
Sydney Melanoma Unit, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|